- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 33/12 - Schistosomicides
Patent holdings for IPC class A61P 33/12
Total number of patents in this class: 83
10-year publication summary
|
4
|
5
|
1
|
5
|
5
|
2
|
3
|
2
|
2
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Nihon Nohyaku Co., Ltd. | 331 |
3 |
| The University of Tokyo | 4285 |
3 |
| Merck Patent GmbH | 5727 |
2 |
| The Board of Trustees of the University of Illinois | 2731 |
2 |
| Aberystwyth University | 40 |
2 |
| Board of Regents of the University of Nebraska | 783 |
2 |
| Monash University | 723 |
2 |
| Rush University Medical Center | 308 |
2 |
| Swiss Tropical and Public Health Institute | 9 |
2 |
| Tongli Biomedical Co., Ltd | 30 |
2 |
| University College Cardiff Consultants Limited | 265 |
2 |
| University of Georgia Research Foundation, Inc. | 1059 |
2 |
| University of L'Aquila | 5 |
2 |
| Zhejiang Hisun Pharmaceutical Co., Ltd. | 287 |
2 |
| Villya LLC | 13 |
2 |
| Centre National de La Recherche Scientifique | 10801 |
1 |
| Bayer Intellectual Property GmbH | 2439 |
1 |
| Wisconsin Alumni Research Foundation | 3927 |
1 |
| DSM IP Assets B.V. | 5479 |
1 |
| University of Florida Research Foundation, Inc. | 4110 |
1 |
| Other owners | 46 |